Stevanato Group (NYSE:STVN) Receives “Equal Weight” Rating from Morgan Stanley

Morgan Stanley restated their equal weight rating on shares of Stevanato Group (NYSE:STVN) in a report released on Monday morning, Benzinga reports. Morgan Stanley currently has a $30.00 target price on the stock.

A number of other research firms also recently weighed in on STVN. Stephens reaffirmed an overweight rating and set a $38.00 price target on shares of Stevanato Group in a research note on Monday, March 25th. BNP Paribas began coverage on Stevanato Group in a research note on Monday. They set an outperform rating for the company. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and an average price target of €33.63 ($35.77).

Stevanato Group Stock Up 0.8 %

Shares of NYSE STVN opened at €27.52 ($29.28) on Monday. Stevanato Group has a one year low of €23.00 ($24.47) and a one year high of €36.30 ($38.62). The business has a 50-day moving average price of €30.08 and a two-hundred day moving average price of €29.45. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 14.31% and a net margin of 13.43%. The firm had revenue of €320.60 million for the quarter, compared to analysts’ expectations of €326.85 million. During the same period last year, the business earned $0.19 earnings per share. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, equities analysts expect that Stevanato Group will post 0.67 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in STVN. William Blair Investment Management LLC bought a new position in shares of Stevanato Group in the 3rd quarter valued at approximately $26,195,000. TimesSquare Capital Management LLC increased its position in Stevanato Group by 64.2% in the 3rd quarter. TimesSquare Capital Management LLC now owns 2,032,361 shares of the company’s stock worth $60,402,000 after buying an additional 794,391 shares during the period. Conestoga Capital Advisors LLC increased its position in Stevanato Group by 19.7% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 4,534,088 shares of the company’s stock worth $134,753,000 after buying an additional 746,136 shares during the period. Sands Capital Management LLC increased its position in Stevanato Group by 46.5% in the 3rd quarter. Sands Capital Management LLC now owns 1,854,880 shares of the company’s stock worth $55,127,000 after buying an additional 588,757 shares during the period. Finally, Riverbridge Partners LLC increased its position in Stevanato Group by 78.1% in the 4th quarter. Riverbridge Partners LLC now owns 1,274,805 shares of the company’s stock worth $34,789,000 after buying an additional 559,070 shares during the period.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.